Regeneron Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 178 U.S.-traded ETFs. REGN has around 7.8M shares in the U.S. ETF market. The largest ETF holder of REGN is the Invesco QQQ Trust (QQQ), with approximately 1.17M shares. Investors may also find of interest that the ETF with the largest allocation to REGN stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 5.67%. On average, U.S. ETFs allocate 0.69% of REGN to their portfolios.
Additionally, REGN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with REGN as a holding is the Invesco DWA Healthcare Momentum ETF (PTH), with a return of 26.78%.